|
Status |
Public on Aug 29, 2024 |
Title |
AC1.230, 72hr, 2 |
Sample type |
SRA |
|
|
Source name |
HEK293F
|
Organism |
Homo sapiens |
Characteristics |
cell line: HEK293F genotype: WT, clonal treatment: 72hr post-transfection
|
Treatment protocol |
HEK293 cells were resuspended in fresh Expi293™ expression medium at a density of 2.5M/ml and triple-transfected with TransIT-VirusGEN and a pHelper plasmid, a RepCap9 plasmid and an ITR containing reporter plasmid.
|
Growth protocol |
HEK293 cells were maintained in suspension in Expi293™ expression medium on an orbital shaker (125 rpm,19 mm orbital throw) in a 37°C, 5% CO2 incubator.
|
Extracted molecule |
polyA RNA |
Extraction protocol |
Total RNA was extracted from cell pellets before and during AAV production. RNA was extracted using Direct-zol-96 RNA Kit. mRNA libraries were constructed by SeqMatic using the Illumina Stranded mRNA prep kit.
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina NovaSeq X |
|
|
Data processing |
Reads were aligned to the human genome via Hisat2 with default parameters. Genomic features were counted using Subread featurecounts with default parameters. Assembly: Homo sapiens GRCh38.84 Supplementary files format and content: Individual CSV file for each sample contains raw counts.
|
|
|
Submission date |
Jun 10, 2024 |
Last update date |
Aug 29, 2024 |
Contact name |
Joshua Tworig |
Organization name |
Ascend Advanced Therapies
|
Street address |
1010 Atlantic Ave., Suite 102
|
City |
Alameda |
State/province |
CA |
ZIP/Postal code |
94501 |
Country |
USA |
|
|
Platform ID |
GPL34281 |
Series (1) |
GSE269485 |
Transcriptomics-informed pharmacology identifies epigenetic and cell cycle regulators as enhancers of AAV production |
|
Relations |
BioSample |
SAMN41775372 |
SRA |
SRX24858220 |